Challenges in MDMA Approval and Upcoming DNC Coverage

This chapter explores the intricate challenges encountered during the MDMA FDA trials, particularly the negative influence of therapist involvement on decision-making. It highlights the significant hurdles still to overcome for FDA approval and discusses its implications for the acceptance of MDMA in therapy while also mentioning upcoming shifts in the show's schedule and a call for listener support.